tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Marc Goodman, 185 are a BUY (77.73%), 47 are a HOLD (19.75%), 6 are a SELL (2.52%).
Analyst Marc Goodman works with a stock forecast success ratio of 60.61% fulfilled within 249 days on average. Previously, Marc Goodman worked at LEERINK.
Marc Goodman’s has documented 433 price targets and ratings displayed on 42 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 11-Mar-2024.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $270 was fulfilled within 3 days with a profit of $41.55 (18.19%) receiving and performance score of 60.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$25.2 (14.84%)
185
22 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$19.2 (11.31%)
181
2 months 12 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$25.2 (14.84%)
180
2 months 12 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-4.8 (-2.83%)
157
3 months 1 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$10.2 (6.01%)
195
3 months 15 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Marc Goodman is most bullish on?
What Year was the first public recommendation made by Marc Goodman?
